Novartis sues Amgen over migraine treatment Aimovig

cafead

Administrator
Staff member
  • cafead   Apr 04, 2019 at 12:12: PM
via Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotech of trying to back out of the companies' agreements to develop and market Aimovig for the prevention of migraines.

article source